tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market
KZR
Kezar Life Sciences
RESEARCH TOOLSreports
Want to see KZR full AI Analyst Report?

Kezar Life Sciences (KZR) Financial Statements

474 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently $54.60M. The company's EPS TTM is $-7.66; its P/E ratio is -0.79; Kezar Life Sciences is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 7.00M$ 0.00$ 0.00
Gross Profit$ -897.00K$ -1.04M$ 7.00M$ 0.00$ -1.51M
Operating Income$ -52.27M$ -90.61M$ -111.42M$ -71.16M$ -54.66M
EBITDA$ -51.37M$ -81.10M$ -99.25M$ -66.03M$ -52.96M
Net Income$ -56.03M$ -83.74M$ -101.87M$ -68.24M$ -54.63M
Balance Sheet
Cash & Short-Term Investments$ 71.88M$ 132.25M$ 201.37M$ 276.56M$ 208.35M
Total Assets$ 76.65M$ 144.68M$ 221.24M$ 299.57M$ 217.93M
Total Debt$ 2.33M$ 16.18M$ 18.93M$ 21.26M$ 14.04M
Net Debt$ -69.55M$ -25.57M$ -16.56M$ -19.19M$ -48.84M
Total Liabilities$ 6.57M$ 27.77M$ 33.66M$ 29.70M$ 21.06M
Stockholders' Equity$ 70.07M$ 116.92M$ 187.57M$ 269.87M$ 196.88M
Cash Flow
Free Cash Flow$ -51.78M$ -74.24M$ -83.45M$ -60.42M$ -42.75M
Operating Cash Flow$ -51.78M$ -74.21M$ -81.64M$ -58.85M$ -42.44M
Investing Cash Flow$ 92.46M$ 80.43M$ 76.05M$ -91.39M$ -28.44M
Financing Cash Flow$ -10.59M$ 103.00K$ 638.00K$ 127.86M$ 112.58M
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Income Statement >

Kezar Life Sciences Debt to Assets

Balance Sheet >

Kezar Life Sciences Cash Flow

Cash Flow >

Kezar Life Sciences Forecast EPS vs Actual EPS

Earnings >